How to identify and mitigate neurologic AEs when treating with CAR-T and T-cell engagers?

During the EHA2021 Virtual Congress, the Multiple Myeloma Hub spoke with Hermann Einsele,...

Selinexor, pomalidomide, and dexamethasone for the treatment of relapsed/refractory multiple myeloma

Selinexor is an oral first-in-class selective inhibitor of nuclear export that inhibits exportin 1...

Dara-Rd for patients with NDMM ineligible for transplant: 5-year follow-up of the MAIA trial

Current frontline treatment with lenalidomide and dexamethasone is unable to produce durable responses in...

Outcomes of triple-class exposed/refractory disease in real-world care: What is the current SoC?

During the ASCO 2021 Annual Meeting, the Multiple Myeloma Hub spoke with Maria Victoria Mateos,...

How to identify and mitigate neurologic AEs when treating with CAR-T and T-cell engagers?

During the EHA2021 Virtual Congress, the Multiple Myeloma Hub spoke with Hermann Einsele,...

How do MM cells develop resistance to BCMA-targeted agents? Can it be overcome in the clinic?

During the EHA2021 Virtual Congress, the Multiple Myeloma Hub spoke with Leo Rasche, University Hospital...

Elranatamab, a subcutaneous BCMA/CD3 bispecific antibody, in patients with RRMM: Findings from the MagnetisMM-1 trial

Elranatamab (PF-06863135) is a bispecific antibody (IgG2a) targeting the B-cell...

What are the major advances for the triple-class exposed population?

During the EHA2021 Virtual Congress, the Multiple Myeloma Hub spoke with Maria-Victoria Mateos, University Hospital of Salamanca,...

Attenuated responses to COVID-19 vaccination in patients with hematologic malignancies

Patients with hematologic malignancies have an increased risk of infections, due to disease-related immune...

COVID-19 vaccination for hematopoietic stem cell transplant patients

The SARS-CoV-2 pandemic has changed the world over the last year and impacted almost every part of our lives. In particular,...

What are the major challenges for CAR T-cell therapies in Europe during the COVID-19 pandemic?

During the Virtual 47th Annual Meeting of the European Society for Blood and Marrow Transplantation...

NCCN COVID-19 vaccination recommendations for patients with hematologic malignancies

Patients with cancer are at high risk of COVID-19-associated complications and, accordingly, the preliminary...